Literature DB >> 10580961

Size of colorectal liver metastases at abdominal CT: comparison of precontrast and postcontrast studies.

L N Nazarian1, J H Park, E J Halpern, L Parker, P T Johnson, A S Lev-Toaff, R J Wechsler.   

Abstract

PURPOSE: To investigate whether measurements of hepatic metastases from colorectal carcinoma before contrast material administration are significantly different statistically from measurements after contrast material administration.
MATERIALS AND METHODS: Twenty-four patients with hepatic metastases from colorectal carcinoma underwent spiral computed tomography (CT) with 7-mm collimation. The liver was imaged before and in the portal-dominant phase after intravenous contrast material administration. For each scan, one to three discrete liver lesions were selected for measurement (n = 49). Three experienced radiologists performed independent measurements of the selected lesions on both pre- and postcontrast images at a computer workstation. A three-way analysis of variance (ANOVA) was performed: subjects by raters (the three independent radiologists) by pre- or postcontrast status. The dependent variable was the product of bidimensional measurements.
RESULTS: Sixty-seven percent (33 of 49) of the lesions were measured as larger on precontrast images; 33% (16 of 49), as smaller. There was high interrater reliability, with an intraclass correlation coefficient greater than 0.9 ANOVA showed significant subject, rater, and contrast material effects (P < .001) for the largest lesions in each liver. Contrast material status was a significant factor for all lesion sizes (P < .003).
CONCLUSION: On average, hepatic metastases from colorectal carcinoma are significantly smaller after contrast material administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580961     DOI: 10.1148/radiology.213.3.r99dc29825

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Standardisation of liver MDCT by tracking liver parenchyma enhancement to trigger imaging.

Authors:  H Brodoefel; A Tognolini; G A Zamboni; S Gourtsoyianni; C D Claussen; V Raptopoulos
Journal:  Eur Radiol       Date:  2011-11-05       Impact factor: 5.315

2.  Non-contrast and portal venous phase computed tomography in breast cancer hepatic metastases: comparison of tumor measurements and impact on response assessment.

Authors:  Brian Flemming; Mark D Kovacs; Andrew Hardie; Melissa Picard; Philip F Burchett; Heather Collins; Douglas H Sheafor
Journal:  Acta Radiol Open       Date:  2021-02-27

Review 3.  Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society.

Authors:  J E Husband; L H Schwartz; J Spencer; L Ollivier; D M King; R Johnson; R Reznek
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

4.  Is Non-Contrast CT Adequate for the Evaluation of Hepatic Metastasis in Patients Who Cannot Receive Iodinated Contrast Media?

Authors:  Han Bum Jee; Min Jung Park; Hye Sun Lee; Mi-Suk Park; Myeong-Jin Kim; Yong Eun Chung
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.